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Fungal infections due to Candida species represent an important cause of nosocomial bloodstream infec-
tions. We report a large pseudo-outbreak of Candida guilliermondii fungemia that occurred in a university
hospital in Brazil. C. guilliermondii was identified in 64 (43%) of the 149 blood samples drawn between June
2003 and July 2004. The samples were from patients in different wards of the hospital but concentrated in
pediatric units. None of the patients had clinical signs of fungemia, and observational analysis revealed errors
in the collection of blood samples. During the investigation of the pseudo-outbreak, C. guilliermondii was
isolated from environmental surfaces and from the skin and nails of members of the nursing team. Through
a subtyping analysis it was found that some of the nonpatient isolates were highly related to the patient
isolates, and all the patient isolates were highly related. This is consistent with the hypothesis that the
pseudo-outbreak was from a limited number of common sources. The adoption of intervention measures was
effective in resolving the outbreak, supporting the hypothesis that the outbreak was due to poor techniques of
drawing blood samples for culture.
Fungal infections due to Candida species represent an im-
portant cause of nosocomial bloodstream infections (18, 20).
Candida is the fourth most prevalent cause of nosocomial
bloodstream infections in Brazil, with an incidence of 2.49
cases per 1,000 hospital admissions, and a crude mortality of
54% (1). Candida guilliermondii is an infrequent, but not un-
usual, agent of candidiasis and has been described as an emerg-
ing pathogen. As reviewed by Krcmery and Barnes (7), over a
40-year period ending in 1990, only 10 cases of C. guilliermondii
fungemia had been reported, whereas 33 cases were reported
between 1990 and 2002. In that study, the rate of fungemia due
to C. guilliermondii varied from 0 to 0.7% in the period be-
tween 1950 and 1990 and from 0.7 to 5.5% from 1991 to 1998.
Most cases of C. guilliermondii infection are associated with
oncology patients (8, 16, 19). A review of the cases of fungemia
in oncology patients reported from 1960 to 1990 showed that
10 cases (0.7%) were due to C. guilliermondii, with three deaths
(19). In Brazil, a study conducted in six hospitals from Sa˜o
Paulo and Rio de Janeiro by Colombo et al. (2) showed three
cases of C. guilliermondii infection among 145 Candida blood-
stream infection patients. In another study involving 11 Bra-
zilian institutions, C. guilliermondii accounted for 2.4% of 712
candidemias (1). Outbreak investigations involving these or-
ganisms must distinguish reliably among the various species
involved. Most strains of C. guilliermondii are morphologically
and biochemically indistinguishable from Candida famata (te-
leomorph Debaromyces hansenii), and nucleic-acid based
methods are usually required to distinguish reliably between
the two species. Recently, C. guilliermondii has been further
subdivided by the addition of two new species in the C. guilli-
ermondii clade: Pichia caribbica (Candida fermentati) and Can-
dida carpophila (15). These three species are also biochemi-
cally indistinguishable. The objective of the present study was
to investigate a large pseudo-outbreak due to C. guilliermondii
isolated from blood cultures during the period between April
2003 and July 2004.
MATERIALS AND METHODS
Background. Hospital Sa˜o Paulo is a teaching hospital associated with the
Federal University of Sa˜o Paulo (UNIFESP), located in Sa˜o Paulo, Brazil. It has
around 680 beds and several units, some of them for pediatric patients, distrib-
uted in 10 wards, and one emergency department.
Observational analysis. The isolation of a yeast-like fungus identified as C.
guilliermondii in blood cultures mainly obtained from the Pediatric Emergency
Department (Pediatric ED) of Hospital Sa˜o Paulo was noticed during epidemi-
ological surveillance in July 2003. C. guilliermondii was isolated from patients
without previous exposure to risk factors for candidemia and who did not present
any clinical evidence of systemic infection. After a retrospective analysis of the
data relative to the isolation of C. guilliermondii, an investigation was started by
the Hospital Infection Control Committee (HICC).
Considering the possibility of a pseudo-outbreak, an observational study was
performed by the epidemiologist, clinicians, and nurses of the HICC to evaluate
the appropriateness of the techniques used for drawing blood samples for culture
at the pediatric ED. The collection procedures were observed for 2 hours every
shift for 10 days in January 2003. Individuals collected data on drawing blood,
including hand hygiene procedures, use of individual protection devices, and
preparation of the patient’s skin. There was no intervention from the observers.
We evaluated the adherence to the local guidelines for blood sample collection
(see Table 3). The local guidelines are as follows. Place a tourniquet above the
venipuncture site. Palpate and locate the vein. Decontaminate skin. It is critical
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to disinfect the venipuncture site meticulously with 10% povidone iodine or 70%
isopropyl alcohol by swabbing the skin concentrically from the center of the
venipuncture site outwards. Let the disinfectant evaporate. Do not repalpate the
vein again. Perform venipuncture. Decontaminate the rubber septum of the blood
vial with 70% alcohol only. Obtain a 20-ml sample and divide it between aerobic
and anaerobic blood culture bottles. It is recommended that two sets be collected
in a 24-hour period. Specimens should not be drawn through the catheter or
cannula unless a concomitant peripheral draw is obtained. The blood culture
bottles should be sent immediately to the microbiology laboratory.
Collection and processing of samples. In the pediatric unit, multiple environ-
mental cultures for fungi were obtained from povidone iodine and alcohol
antiseptic solution, paper towels, and cotton. Each selected material was placed
in a flask with 250 ml sterile distilled water and allowed to settle. The total
volume was centrifuged at 4,000 rpm for 15 min, the supernatant was removed,
and the pellet was streaked on plates containing Sabouraud dextrose agar with
chloramphenicol.
A wet cotton swab was used for collecting samples from a sphygmomanometer
cuff, soap tray, tray, sink, and drain. Each swab was streaked on the surface of a
plate containing Sabouraud dextrose agar with chloramphenicol.
All 32 members of the nursing team of the pediatric unit were examined for
evidence of dermatological disease. Samples from toenails and fingernails were
collected with a sterile scalpel, and the resulting fragments were checked for
fungal elements by direct microscopy as well as cultured on plates containing
Sabouraud dextrose agar with chloramphenicol. Hand colonization was checked
by sampling the palms and fingers of all nurses with a sterile filter paper con-
taining 0.02% Tween 80. The collected filter papers were placed in 50-ml Falcon
tubes and shaken for 15 min. The liquid was removed and centrifuged at 4,000
rpm for 15 min. The supernatant was discarded, and the pellet was streaked on
plates containing Sabouraud dextrose agar with chloramphenicol.
All cultures were incubated at 30°C for 5 days. Isolated colonies were
subcultured on chromogenic medium CHROMagar Candida (CHROMagar
Microbiology, Paris, France) and incubated at 30°C for 72 h. Colonies rep-
resentative of the cultures were individually picked for identification. Species
identification was based on characteristics of micromorphology, and biochem-
ical tests were performed with the commercial system ID 32 C (bioMe´rieux,
Marcy l’E´toile, France).
DNA subtyping. A total of 54 isolates of C. guilliermondii, C. famata, and
related species were used for the subtyping analysis (Table 1). These isolates
were classified into three groups. Group 1 consisted of 25 isolates from the
hospital cluster. These are termed Brazilian cluster (or outbreak) strains. Twenty
of these isolates were from blood cultures. The remaining five isolates, labeled 21
to 25, were from three nurses’ hands, and two environmental sources related to
the cluster (sphygmomanometer cuff and paper towel). Group 2 consisted of nine
isolates from South America that were not involved in the cluster and were
obtained as a kind gift from M. Pfaller (University of Iowa, Iowa City). They are
termed South American control strains. Group 3 consisted of 20 unrelated
strains from the CDC reference collection. These are termed U.S. nonoutbreak
control strains. Nineteen of these isolates were defined as C. guilliermondii by
DNA-based methods, either using a DNA probe specific for the C. guilliermondii
clade (3) or through direct DNA sequencing of ribosomal DNA. The last isolate
(B6832) is the type strain for C. carpophila (15).
All 54 isolates were analyzed by randomly amplified polymorphic DNA
(RAPD) fingerprinting using eight primers individually. Primers are given in
Table 2. The four primers listed as UBC147, UBC194, UBC734, and UBC738
have been used previously in a C. guilliermondii outbreak investigation (12).
These primers were originally described by Zeng et al. (22). The remaining four
primers (Table 2) were from a panel of RAPD primers previously used for other
species and found empirically to give fingerprint patterns (10). In addition, all
isolates were analyzed by HinfI digestion of total genomic DNA. This technique
for strain and Candida species identification was originally described by Fujita
and Hashimoto (5).
For RAPD profile analysis, DNA was prepared from fresh YEPD (1% yeast
extract, 2% peptone, 1% dextrose) slant cultures using a Mo Bio Microbial DNA
isolation kit (Mo Bio Laboratories, Inc., Solana Beach, CA) according to the
recommendations of the manufacturer. For HinfI analysis, DNA was prepared
from overnight 25-ml YEPD cultures using standard techniques as previously
described (9). Basically, this consists of lysing spheroplasts, followed by protein-
ase K digestion, phenol extraction, and ethanol precipitation. Overnight diges-
tions of genomic DNA with HinfI (Roche, Indianapolis, IN) at 37°C were
electrophoresed on 1.0% agarose at 5 g/lane, followed by ethidium bromide
staining.
For RAPD profiling, PCR conditions were as previously described (9), using
RAPD primers individually as listed in Table 2. Amplification conditions were as
follows: 5-min denaturation at 95°C, 35 cycles (with 1 cycle consisting of 1 min at
95°C, 1 min at 25°C, and 1 min at 72°C), and a final 5-min extension at 72°C. The
entire reaction mixture (20-l total volume) was electrophoresed on individual
lanes of a 2% Metaphor agarose gel (FMC Corp., Rockland, MA). Molecular
size standards (number 9) were from Roche (Indianapolis, IN). RAPD finger-
print patterns were analyzed using Bionumerics (Applied Maths, Austin, TX)
software.
TABLE 1. Strains used in this study
Strain and CDC no. or
ATCC strain no.
Description (sample no.)
or source Genotype
a
Brazilian outbreak strains
(group 1)
2004010326 Patient isolate (1CG) I, B
2004010327 Patient isolate (2CG) I, B
2004010328 Patient isolate (3CG) I, B
2004010329 Patient isolate (4CG) I, B
2004010330 Patient isolate (5CG) I, B
2004010331 Patient isolate (6CG) I, B
2004010332 Patient isolate (7CG) I, B
2004010333 Patient isolate (8CG) I, B
2004010334 Patient isolate (9CG) I, B
2004010335 Patient isolate (10CG) I, B
2004010336 Patient isolate (11CG) I, B
2004010337 Patient isolate (12CG) I, B
2004010338 Patient isolate (13CG) I, B
2004010339 Patient isolate (14CG) I, B
2004010340 Patient isolate (15CG) I, B
2004010341 Patient isolate (16CG) I, B
2004010342 Patient isolate (17CG) I, B
2004010443 Patient isolate (18CG) I, B
2004010444 Patient isolate (19CG) I, B
2004010445 Patient isolate (20CG) I, B
2004010446 Isolate 21 from a nurse (21CG) I, B
2004010447 Isolate 22 from a nurse (22CG) I, B
2004010448 Isolate 23 from a nurse (23CG) I, B
2004010449 Isolate 24 from a sphygmomanometer
cuff (24CG)
I, B
2004010450 Isolate 25 from paper towel I, B
South American control
strains (group 2)
20233.092 São Paulo, Brazil I, C
20313.020 Santa Fe, Argentina I, C
20319.018 São Paulo, Brazil I, C
20336.020 Bogota, Colombia I, A
20337.052 Medellin, Colombia I, C
20337.091 Medellin, Colombia I, B
20352.081 Quito, Ecuador III, F
20361.066 Buenos Aires, Argentina III, D
20416.031 Bogota, Colombia I, A
U.S. nonoutbreak control
strains (group 3)
2002015519 I, C
2002500017 III, D
200201523/CAS00-0036 II, I
200201524/CAS00-0037 III, F
2002200337/B6222 I, C
MAS92-0058 I, C
MAS92-0116 I, ?
MAS93-0313 III, E
MAS93-0386 I, B
MAS93-0623 II, G
MAS93-0975 I, B
MAS93-1057 II, G
LM17-95 I, C
LM549-96 I, ?
LM823-96 II, H
LM965-96 I, B
B4346 I, B
B4347 I, B
KORG1 I, C
B6832 C. carpophila type strain II, H
ATCC strains
ATCC 42715 C. guilliermondii I, A
ATCC 6260 C. guilliermondii type strain I, A
a Roman numerals refer to the RAPD group, and the letters refer to the HinFI
type.
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Adoption of intervention measures. The first intervention measure, involving
lectures for the medical and nursing teams of the pediatric units, was adopted in
March 2004. The importance of complying with guidelines for infection control,
including hand hygiene and techniques for blood collection as described in the
hospital manuals, were the main topics discussed. Despite the adoption of these
measures, some cases of C. guilliermondii-positive blood cultures were still ob-
served in the pediatric units, which led the HICC to determine that blood
samples should be drawn by a specialized professional. Members of the nursing
staff, from different sectors and working different shifts, were later selected for
the task of blood collection. In April 2004, the second intervention procedure,
involving the theoretical and practical training of these workers, was established.
Training included all the steps of the technique of drawing blood samples for
culture, related to hand hygiene, aseptic preparation of the patient’s skin, prep-
aration of the material for collection, and additional care measures during the
procedure.
RESULTS
C. guilliermondii was identified in 64 (43%) of the 149 blood
cultures between June 2003 and July 2004. The samples were
from patients hospitalized in different wards but were concen-
trated in pediatric units (Fig. 1). A total of 51 (79.7%) blood
cultures positive for C. guilliermondii were obtained from pe-
diatric units: 24 (47.1%) were from the Pediatric ED, and 27
(52.9%) from other pediatric units. The remaining 13 (20.3%)
positive blood cultures were derived from adult patients. Re-
sults from the clinical and epidemiological investigation of the
cases suggested a pseudo-outbreak, since most of the patients
had not been submitted to invasive procedures or exposed to
factors which could be associated with Candida infections. The
patients were, furthermore, mainly from pediatric emergency
wards, and many of them did not show signs or clinical symp-
toms of severe infection and were not hospitalized. No deaths
occurred, even when the patients were not treated. During the
first stage of the study, 15 sessions of blood collection involving
different members of the medical and nursing staff were ob-
served. Analysis of the forms filled in during each session
showed the existence of flaws in the procedures of hand wash-
ing and asepsis by the health care workers, as well as during
preparation of the patient’s skin for drawing blood (Table 3).
These results confirm the lack of adherence to guidelines for
blood collection established by the hospital.
During the pseudo-outbreak, C. guilliermondii was isolated
during culture of blood samples from different units of the
hospital, with important concentration of patients from pedi-
atric units (51 of 64; 79.7%) which included the Pediatric ED.
The standard technique for the collection of blood samples is
puncture of the cubital vein at the elbow. In the patients where
this method was not possible, blood was obtained from a scalp
vein.
The microbiological investigation of materials and surfaces
showed the presence of C. guilliermondii in the sphygmoma-
nometer cuff, paper towels, and sink drain at the Pediatric ED.
The fungus was not detected in samples of cotton, gauze, tape,
antiseptic solution, from the tray, from the surface of the soap
tray or sink, and from the vials used for blood collection.
Analysis of the samples collected from the 32 members of the
nursing staff showed that 20 (79%) were colonized with fungi,
and that in 7 cases (21%), the colonization was due to C.
guilliermondii. As part of the intervention measures, the pro-
fessionals were sent to be evaluated by a specialized physician,
who concluded that none of the individuals displayed skin or
nail fungal infections.
The pseudo-outbreak was completely resolved when blood
samples began to be collected only by members of the nursing
team assigned to this task and adequately trained according to
institutional standards.
Subtyping of C. guilliermondii isolates. (i) Group 1 (Brazil-
ian pseudo-outbreak strains). For seven of the eight RAPD
primers, we observed no reproducible differences among the
25 isolates. Each RAPD primer gave a different fingerprint
profile, which was shared by all isolates in this group (data not
shown). However, all primers gave different patterns for the
nonoutbreak isolates as discussed below. We conclude, there-
fore, that the primers can detect differences between strains
TABLE 2. Primers used in the RAPD analysis of 54 isolates
Primer Sequence
UBC147 (405624) .......................GTGCGTCCTC
UBC194 (405625) .......................AGGACGTGCC
UBC734 (405626) .......................GGAGAGGGAG
UBC738 (405627) .......................GGTGGGTGGT
RAPD2 (300960) ........................CACATGCCT
PAO3............................................AGTCAGCCAC
M13core .......................................GAGGGTGGCGTTCT
ERIC1R.......................................ATGTAAGCTCCTGGGGATTCAC
FIG. 1. Distribution of C. guilliermondii cases isolated at the Hos-
pital Sa˜o Paulo, Sa˜o Paulo, Brazil, from April 2003 to July 2004 and
intervention measures. The numbers on the y axis and in the bars are
the numbers of cases.
TABLE 3. Parameters considered during the observational analysis
of the collection of blood samples and resulting
observations (n  15)
Parameter No. ofobservations (%)
Product for hand hygiene
Common soap......................................................................11 (73.3)
Chlorhexidine (2%) ............................................................ 3 (20.0)
None ..................................................................................... 1 (6.7)
Product for aseptic prepn of the puncture site
Common soap...................................................................... 9 (60.0)
Iodopolvidine solution........................................................ 1 (6.7)
70% alcohol ......................................................................... 5 (33.3)
Type of gloves
Nonsterile (procedure) gloves ........................................... 7 (46.6)
Sterile gloves........................................................................ 8 (53.4)
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and that group 1 outbreak strains are highly related. One
RAPD primer (UBC738 or 405627) could distinguish between
patient strains and some of the environmental strains (isolates
21 to 25). This is shown in Fig. 2. Specifically, isolates 22, 23,
and 24, corresponding to two isolates from two nurses and a
blood pressure cuff (Fig. 2B), lack a major band of approxi-
mately 650 base pairs that was seen in the other blood and
environmental isolates. The other isolates from nurses and
paper towels gave patterns matching the patients’ isolates.
These experiments were repeated using different DNA prep-
arations and gave identical results.
HinfI digestion resulted in four major bands at 2.9, 2.6, 2.4,
and 2.3 kb; representative patterns are shown in Fig. 3, which
shows strains 21 to 25 (environmental strains). All 25 strains
gave identical patterns, which has been subsequently termed
pattern B. This gives additional support for the concept that
outbreak strains are highly related.
(ii) Analysis of all groups. All eight RAPD primers consis-
tently gave the same results. Although the patterns were dif-
ferent for each primer, there were no inconsistencies between
profile types. The results for primer UBC738 are shown in Fig.
2, with South American control strains shown in Fig. 2A, U.S.
control strains in Fig. 2A and B, and Brazilian strains in Fig. 2B
and C. These data were used as part of a cluster analysis with
primer UBC147 (Fig. 4) and can be summarized as follows.
RAPD profiles cluster into three major groups, termed I, II,
and III. We observed a subgroup of group I, termed I. Mem-
bers of the I group differ by one or two bands from group I. All
Brazilian pseudo-outbreak strains were found to be members
of group I (only three representative strains are shown in the
cladogram). Group I members also include ATCC 42715 and
strain ATCC 6260, the type strain for C. guilliermondii. Group
II includes isolates similar to Candida (Torulopsis) carpophila
(5, 15). Group III includes strains with HinfI patterns similar to
those of Candida (Torula) fermentati (15) and was consistent
with DNA sequence information obtained from selected mem-
bers of this group. We conclude, therefore, that RAPD finger-
FIG. 2. RAPD fingerprints of Brazilian cluster strains using primer
UBC738 or 405627. (A) South American control and U.S. control
strains. (B) U.S. control and Brazilian outbreak strains 2004010446 to
2004010450 (21 to 25, respectively, in text). The white arrow indicates
the absence of bands for isolates 22 to 24. (C) Brazilian outbreak
strains 2004010326 to 2004010337 (strains 1 to 12, respectively, in text).
I to III in the lanes show examples of the three representative groups.
M, molecular size markers.
FIG. 3. HinfI digestion pattern B for five environmental isolates in
the Brazilian cluster strains. Molecular sizes (in kilobases) are shown
at the sides of the gel.
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print profiles can distinguish between distinct taxonomic groups
at the species level.
The HinfI profiles were found to subdivide members of
RAPD groups I to III further, consistent with the partitioning
of the three groups. We observed a total of eight different
HinfI patterns, termed A to H (data not shown). All RAPD
group I strains had pattern A, B, or C. RAPD group II and III
strains had patterns E to H. Each strain had a distinct, indi-
vidual pattern. All 25 Brazilian outbreak strains were HinfI
pattern B (Fig. 3). Therefore, their combined RAPD/HinfI
genotype was I, B. The individual genotypes for all 54 strains in
this study are given in Table 1. In addition, we observed that
HinfI patterns A, B, and C were related by the simple gain or
loss of a HinfI site. For example, pattern B (four bands) is
related to pattern A (three bands) by the loss of the 2.9-kb
fragment. This could be explained by the gain of a site in this
fragment. These data are consistent with the concept of a
single taxonomic group (group I) with single nuclear polymor-
phisms within the HinfI fragments. HinfI patterns D to H were
associated with RAPD groups II and III. These patterns were
more complex and presumably not just the simple gain or loss
of a restriction site. Again, this is consistent with the findings
that RAPD groups II and III are taxonomic entities distinct
from RAPD group I and from each other. The segregation of
these isolates into three HinfI patterns (A to C) can further
subdivide conventionally indistinguishable C. guilliermondii
strains. Approximately 50% (7 of 16) nonoutbreak RAPD
group I control strains showed HinfI pattern B, with the re-
mainder divided between patterns A and C.
DISCUSSION
Although C. guilliermondii is known to be invasive, hospital
outbreaks are very rare and few reports are known. A pseudo-
outbreak of C. guilliermondii infection, due to the contamina-
tion of heparin vials in a neonatal intensive care unit (17
babies) (21), and a hospital outbreak of C. guilliermondii re-
sulting in invasive infection (n  5) have been previously re-
ported (12). Nonfungal pseudo-outbreaks of positive blood
cultures have been found associated with contamination of the
environment in which the blood was collected, use of contam-
inated gloves, disinfectants, collection tubes, or blood culture
media and during sampling with an automated blood culture
system (6, 11, 14).
Microorganisms on the skin of the patients or health care
workers may be introduced into blood sample vials due to lack
of adherence to good practices for control of hospital infection,
with results that can be measured in both financial and human
terms. One study showed that contaminated blood cultures can
result in an increase of around 4.5 days in hospital stay and of
more than $5,000 in the cost of treatment (13). According to
standards published by the American Society for Microbiology,
the rates of contamination of blood cultures should not exceed
3% (17), but it is not possible to eliminate all suspicious false-
positive results. Some suspicious contaminations, in fact, may
be associated with transitory bacteremias (17).
A number of factors have previously been shown to be im-
portant in interpreting the results of blood culture. These in-
clude training the workers who collect blood, selection and
preparation of the puncture site, use of equipment for individ-
ual protection during blood collection, and volume of blood
collected. A study by the College of American Pathologists
showed that when blood is collected by nontrained personnel,
a culture contamination rate of 77% is observed (14). The
lowest contamination rates, on the other hand, are seen in
facilities where specialized personnel are available (14).
Selection of the puncture site has a significant impact in the
possibility of contamination of the blood culture. Collection of
blood from areas involving peripheral or central vascular de-
vices result in high contamination rates. Such invasive devices
are maintained during long periods of time and are thus sus-
ceptible to colonization by microorganisms, which multiply and
accumulate around the invasive ports and can thus be pulled
into blood specimens collected from those sites and introduced
into the blood culture vials (4).
Aseptic preparation of the puncture site is without question
the most important factor in the collection of blood samples.
Several antiseptics may be used for preparing the patient’s
skin, as long as compatibility of the products and the length of
time they need to work are considered. Contamination of the
puncture site is most likely when the access points are difficult
to locate and the professional needs to repalpate the already
aseptically prepared site (4).
The early identification of a pseudo-outbreak has great im-
portance, as the patients may be unnecessarily treated, submit-
FIG. 4. Cluster analysis of RAPD fingerprint patterns obtained
with primers UBC147 and UBC738 by the unweighted-pair group
method using average linkages. The 29 nonoutbreak strains and three
examples of the outbreak strains are shown. Roman numerals I to III
correspond to the three major taxonomic groups. Percent relatedness
is shown on the horizontal axis.
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ted to invasive procedures, have their hospitalization period
extended, and have the real cause of their symptoms over-
looked (11).
It was concluded from the subtyping results that the pseudo-
outbreak strains from the patients are similar and are related
to some of the environmental strains. This supports the hy-
pothesis that this cluster originated from one or a limited
number of common sources. This is consistent with the epide-
miological findings.
It can be concluded that all the intervention measures
adopted were important for resolving the pseudo-outbreak,
but the single most important factor was the selection and
training of blood collection personnel, showing the importance
of the involvement of the health care workers, together with
administrative measures.
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